Role of the renin-angiotensin system in the development of severe COVID-19 in hypertensive patients

Detalhes bibliográficos
Autor(a) principal: Silva Junior, Rodrigo Pacheco
Data de Publicação: 2020
Outros Autores: Peruchetti, Diogo Barros, Rocco, Patricia Tieken Macedo, Schmaier, Alvin H., Silva, Patrícia Machado Rodrigues e, Martins, Marco Aurélio, Carvalho, Vinícius Frias, Pinheiro, Ana Acácia Sá, Neves, Celso Caruso
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Repositório Institucional da FIOCRUZ (ARCA)
DOI: 10.1152/ajplung.00286.2020
Texto Completo: https://www.arca.fiocruz.br/handle/icict/45485
Resumo: Universidade Federal do Rio de Janeiro. Instituto de Biofísica Carlos Chagas Filho. Rio de Janeiro, RJ, Brasil.
id CRUZ_6a1f1a1b9e5112f33b392d73887ff61e
oai_identifier_str oai:www.arca.fiocruz.br:icict/45485
network_acronym_str CRUZ
network_name_str Repositório Institucional da FIOCRUZ (ARCA)
repository_id_str 2135
spelling Silva Junior, Rodrigo PachecoPeruchetti, Diogo BarrosRocco, Patricia Tieken MacedoSchmaier, Alvin H.Silva, Patrícia Machado Rodrigues eMartins, Marco AurélioCarvalho, Vinícius FriasPinheiro, Ana Acácia SáNeves, Celso Caruso2021-01-01T19:55:32Z2021-01-01T19:55:32Z2020AGUIAR, Rodrigo Pacheco Silva et al. Role of the renin-angiostensin system in the development and SARS-CoV-2 infection. American Journal of Physiology. Lung Cellular and Molecular Physiology, v. 319, p. L596-L602, 2020.1040-0605https://www.arca.fiocruz.br/handle/icict/4548510.1152/ajplung.00286.2020engAmerican Physiological SocietyCOVID-19SARS-CoV-2Angiotensin IIHypertensionSistema renina-angiotensinaCOVID-19SARS-CoV-2Angiotensin IIHypertensionRenin-angiotensin systemRole of the renin-angiotensin system in the development of severe COVID-19 in hypertensive patientsinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/articleUniversidade Federal do Rio de Janeiro. Instituto de Biofísica Carlos Chagas Filho. Rio de Janeiro, RJ, Brasil.Universidade Federal do Rio de Janeiro. Instituto de Biofísica Carlos Chagas Filho. Rio de Janeiro, RJ, Brasil.Universidade Federal do Rio de Janeiro. Instituto de Biofísica Carlos Chagas Filho. Rio de Janeiro, RJ, Brasil / Instituto Nacional de Ciência e Tecnologia de Medicina Reginerativa. Rio de Janeiro, RJ, Brasil / Fundação Carlos Chagas Filho de Amparo à Pesquisa. do Rio de Janeiro. Rede do Rio de Jjaneiro em Inovação em Nanosistemas para a Saúde - NanoSAÚDE. Rio de Janeiro, RJ, Brasil.Case Western Reserve University. Cleveland, Ohio, USA / University Hospitals Cleveland Medical Center. Cleveland, Ohio, USA.Fundação Carlos Chagas Filho de Amparo à Pesquisa. do Rio de Janeiro. Rede do Rio de Jjaneiro em Inovação em Nanosistemas para a Saúde - NamoSAÚDE. Rio de Janeiro, RJ, Brasil / Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Inflamação. Rio de Janeiro, RJ, Brasil.Fundação Carlos Chagas Filho de Amparo à Pesquisa. do Rio de Janeiro. Rede do Rio de Jjaneiro em Inovação em Nanosistemas para a Saúde - NamoSAÚDE. Rio de Janeiro, RJ, Brasil / Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Inflamação. Rio de Janeiro, RJ, Brasil.Fundação Carlos Chagas Filho de Amparo à Pesquisa. do Rio de Janeiro. Rede do Rio de Jjaneiro em Inovação em Nanosistemas para a Saúde - NamoSAÚDE. Rio de Janeiro, RJ, Brasil / Fundação Oswaldo Cruz. Instituto Oswaldo Cruz. Laboratório de Inflamação. Rio de Janeiro, RJ, Brasil.Universidade Federal do Rio de Janeiro. Instituto de Biofísica Carlos Chagas Filho. Rio de Janeiro, RJ, Brasil / Fundação Carlos Chagas Filho de Amparo à Pesquisa. do Rio de Janeiro. Rede do Rio de Jjaneiro em Inovação em Nanosistemas para a Saúde - NanoSAÚDE. Rio de Janeiro, RJ, Brasil.Universidade Federal do Rio de Janeiro. Instituto de Biofísica Carlos Chagas Filho. Rio de Janeiro, RJ, Brasil / Instituto Nacional de Ciência e Tecnologia de Medicina Reginerativa. Rio de Janeiro, RJ, Brasil / Fundação Carlos Chagas Filho de Amparo à Pesquisa. do Rio de Janeiro. Rede do Rio de Jjaneiro em Inovação em Nanosistemas para a Saúde - NanoSAÚDE. Rio de Janeiro, RJ, Brasil.A new form of severe acute respiratory syndrome (SARS) caused by SARS-coronavirus 2 (CoV-2), called COVID-19, has become a global threat in 2020. The mortality rate from COVID-19 is high in hypertensive patients, making this association especially dangerous. There appears to be a consensus, despite the lack of experimental data, that angiotensin II (ANG II) is linked to the pathogenesis of COVID-19. This process may occur due to acquired deficiency of angiotensin-converting enzyme 2 (ACE2), resulting in reduced degradation of ANG II. Furthermore, ANG II has a critical role in the genesis and worsening of hypertension. In this context, the idea that there is a surge in the level of ANG II with COVID-19 infection, causing multiple organ injuries in hypertensive patients becomes attractive. However, the role of other components of the renin angiotensin system (RAS) in this scenario requires elucidation. The identification of other RAS components in COVID-19 hypertension may provide both diagnostic and therapeutic benefits. Here, we summarize the pathophysiologic contributions of different components of RAS in hypertension and their possible correlation with poor outcome observed in hypertensive patients with COVID-19.info:eu-repo/semantics/openAccessreponame:Repositório Institucional da FIOCRUZ (ARCA)instname:Fundação Oswaldo Cruz (FIOCRUZ)instacron:FIOCRUZLICENSElicense.txtlicense.txttext/plain; charset=utf-82991https://www.arca.fiocruz.br/bitstream/icict/45485/1/license.txt5a560609d32a3863062d77ff32785d58MD51ORIGINALVinicusCarvalho_PatriciaTSIlva_etal_IOC_2020.pdfVinicusCarvalho_PatriciaTSIlva_etal_IOC_2020.pdfapplication/pdf303154https://www.arca.fiocruz.br/bitstream/icict/45485/2/VinicusCarvalho_PatriciaTSIlva_etal_IOC_2020.pdfdcfc282d164f6b38f04c25da94f02104MD52TEXTVinicusCarvalho_PatriciaTSIlva_etal_IOC_2020.pdf.txtVinicusCarvalho_PatriciaTSIlva_etal_IOC_2020.pdf.txtExtracted texttext/plain50707https://www.arca.fiocruz.br/bitstream/icict/45485/3/VinicusCarvalho_PatriciaTSIlva_etal_IOC_2020.pdf.txtde30ee4a78abefc10d6800318c1e5a0eMD53icict/454852021-01-04 20:53:49.073oai:www.arca.fiocruz.br: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ório InstitucionalPUBhttps://www.arca.fiocruz.br/oai/requestrepositorio.arca@fiocruz.bropendoar:21352021-01-04T23:53:49Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)false
dc.title.pt_BR.fl_str_mv Role of the renin-angiotensin system in the development of severe COVID-19 in hypertensive patients
title Role of the renin-angiotensin system in the development of severe COVID-19 in hypertensive patients
spellingShingle Role of the renin-angiotensin system in the development of severe COVID-19 in hypertensive patients
Silva Junior, Rodrigo Pacheco
COVID-19
SARS-CoV-2
Angiotensin II
Hypertension
Sistema renina-angiotensina
COVID-19
SARS-CoV-2
Angiotensin II
Hypertension
Renin-angiotensin system
title_short Role of the renin-angiotensin system in the development of severe COVID-19 in hypertensive patients
title_full Role of the renin-angiotensin system in the development of severe COVID-19 in hypertensive patients
title_fullStr Role of the renin-angiotensin system in the development of severe COVID-19 in hypertensive patients
title_full_unstemmed Role of the renin-angiotensin system in the development of severe COVID-19 in hypertensive patients
title_sort Role of the renin-angiotensin system in the development of severe COVID-19 in hypertensive patients
author Silva Junior, Rodrigo Pacheco
author_facet Silva Junior, Rodrigo Pacheco
Peruchetti, Diogo Barros
Rocco, Patricia Tieken Macedo
Schmaier, Alvin H.
Silva, Patrícia Machado Rodrigues e
Martins, Marco Aurélio
Carvalho, Vinícius Frias
Pinheiro, Ana Acácia Sá
Neves, Celso Caruso
author_role author
author2 Peruchetti, Diogo Barros
Rocco, Patricia Tieken Macedo
Schmaier, Alvin H.
Silva, Patrícia Machado Rodrigues e
Martins, Marco Aurélio
Carvalho, Vinícius Frias
Pinheiro, Ana Acácia Sá
Neves, Celso Caruso
author2_role author
author
author
author
author
author
author
author
dc.contributor.author.fl_str_mv Silva Junior, Rodrigo Pacheco
Peruchetti, Diogo Barros
Rocco, Patricia Tieken Macedo
Schmaier, Alvin H.
Silva, Patrícia Machado Rodrigues e
Martins, Marco Aurélio
Carvalho, Vinícius Frias
Pinheiro, Ana Acácia Sá
Neves, Celso Caruso
dc.subject.other.pt_BR.fl_str_mv COVID-19
SARS-CoV-2
Angiotensin II
Hypertension
Sistema renina-angiotensina
topic COVID-19
SARS-CoV-2
Angiotensin II
Hypertension
Sistema renina-angiotensina
COVID-19
SARS-CoV-2
Angiotensin II
Hypertension
Renin-angiotensin system
dc.subject.en.pt_BR.fl_str_mv COVID-19
SARS-CoV-2
Angiotensin II
Hypertension
Renin-angiotensin system
description Universidade Federal do Rio de Janeiro. Instituto de Biofísica Carlos Chagas Filho. Rio de Janeiro, RJ, Brasil.
publishDate 2020
dc.date.issued.fl_str_mv 2020
dc.date.accessioned.fl_str_mv 2021-01-01T19:55:32Z
dc.date.available.fl_str_mv 2021-01-01T19:55:32Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
format article
status_str publishedVersion
dc.identifier.citation.fl_str_mv AGUIAR, Rodrigo Pacheco Silva et al. Role of the renin-angiostensin system in the development and SARS-CoV-2 infection. American Journal of Physiology. Lung Cellular and Molecular Physiology, v. 319, p. L596-L602, 2020.
dc.identifier.uri.fl_str_mv https://www.arca.fiocruz.br/handle/icict/45485
dc.identifier.issn.pt_BR.fl_str_mv 1040-0605
dc.identifier.doi.none.fl_str_mv 10.1152/ajplung.00286.2020
identifier_str_mv AGUIAR, Rodrigo Pacheco Silva et al. Role of the renin-angiostensin system in the development and SARS-CoV-2 infection. American Journal of Physiology. Lung Cellular and Molecular Physiology, v. 319, p. L596-L602, 2020.
1040-0605
10.1152/ajplung.00286.2020
url https://www.arca.fiocruz.br/handle/icict/45485
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.publisher.none.fl_str_mv American Physiological Society
publisher.none.fl_str_mv American Physiological Society
dc.source.none.fl_str_mv reponame:Repositório Institucional da FIOCRUZ (ARCA)
instname:Fundação Oswaldo Cruz (FIOCRUZ)
instacron:FIOCRUZ
instname_str Fundação Oswaldo Cruz (FIOCRUZ)
instacron_str FIOCRUZ
institution FIOCRUZ
reponame_str Repositório Institucional da FIOCRUZ (ARCA)
collection Repositório Institucional da FIOCRUZ (ARCA)
bitstream.url.fl_str_mv https://www.arca.fiocruz.br/bitstream/icict/45485/1/license.txt
https://www.arca.fiocruz.br/bitstream/icict/45485/2/VinicusCarvalho_PatriciaTSIlva_etal_IOC_2020.pdf
https://www.arca.fiocruz.br/bitstream/icict/45485/3/VinicusCarvalho_PatriciaTSIlva_etal_IOC_2020.pdf.txt
bitstream.checksum.fl_str_mv 5a560609d32a3863062d77ff32785d58
dcfc282d164f6b38f04c25da94f02104
de30ee4a78abefc10d6800318c1e5a0e
bitstream.checksumAlgorithm.fl_str_mv MD5
MD5
MD5
repository.name.fl_str_mv Repositório Institucional da FIOCRUZ (ARCA) - Fundação Oswaldo Cruz (FIOCRUZ)
repository.mail.fl_str_mv repositorio.arca@fiocruz.br
_version_ 1822792031626330112